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Caprine arthritis encephalitis virus (CAEV) is the natural lentivirus of goats, well known for its tropism for macrophages and its inability to
cause infection in lymphocytes. The viral genome lacks nef, tat, vpu and vpx coding sequences. To test the hypothesis that when nef is expressed
by the viral genome, the virus became toxic for lymphocytes during replication in macrophages, we inserted the SIVsmm PBj14 nef coding
sequences into the genome of CAEV thereby generating CAEV-nef. This recombinant virus is not infectious for lymphocytes but is fully
replication competent in goat macrophages in which it constitutively expresses the SIV Nef. We found that goat lymphocytes cocultured with
CAEV-nef-infected macrophages became activated, showing increased expression of the interleukin-2 receptor (IL-2R). Activation correlated with
increased proliferation of the cells. Interestingly, a dual effect in terms of apoptosis regulation was observed in exposed goat lymphocytes. Nef was
found first to induce a protection of lymphocytes from apoptosis during the first few days following exposure to infected macrophages, but later it
induced increased apoptosis in the activated lymphocytes. This new recombinant virus provides a model to study the functions of Nef in the
context of infection of macrophages, but in absence of infection of T lymphocytes and brings new insights into the biological effects of Nef on
lymphocytes.
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CAEV is the natural lentivirus of goats that causes persistent
infections in goats all over the world. CAEV was first isolated
from the joint of an arthritic goat and simultaneously from the
brain of an encephalitic kid (Crawford et al., 1980; Narayan et
al., 1980). The virus genome was cloned, fully sequenced and
the genes coding the viral proteins characterized (Saltarelli et
al., 1990, 1994). CAEV of goats like-Maedi Visna virus of⁎ Corresponding author. Present address: The Kansas University of Medical
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doi:10.1016/j.virol.2007.02.032sheep are lentivirus genus members that have a simple genome
that contains only 2 additional regulatory and one accessory
genes in addition to the prototypic retroviral gag, pol and env
genes (Villet et al., 2003a, 2003b; Staskus et al., 1991). Among
retroviruses, the primate lentiviruses HIV and SIV have a
remarkably complex genome containing in addition to the
retroviral genes, several additional open reading frames that
encode three regulatory (Vif, Tat and Rev) and four accessory
proteins (Nef, Vpu, Vpr and Vpx) that play important roles in
pathogenesis of the infection with these viruses. One of the
characteristics of primate lentivirus infection is the progressive
depletion of CD4+ T cells that leads to the development of
AIDS. Nef is well known to be one of the key factors thought to
be involved in this process of causing dysfunction and death of
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Lelievre et al., 2004; Alimonti et al., 2003).
Nef is a 27- to 35-kDa myristylated protein that is expressed
early during the viral life cycle in the cell, but it does not
become incorporated into virus particles. Although the precise
functions of this protein are not fully understood, the results of
studies in rhesus macaques demonstrated that Nef plays a
crucial role for the maintenance of high viral loads and
subsequent development of SIV-specific pathogenesis (Kestler
et al., 1991; Beer et al., 1997). Studies in the in SCID-hu mouse
model confirmed the requirement of Nef for maintenance of
high virus loads of HIV-1 (Gulizia et al., 1997; Aldrovandi et
al., 1998; Aldrovandi and Zack, 1996). As a corollary, structural
studies of the HIV-1 genome revealed that some long-term
survivors of AIDS in patients infected with HIV-1 are
associated with infection with Nef-defective HIV-1 (Deacon
et al., 1995; Rhodes et al., 2000).
Several studies have shown that the productive phase of
replication of HIV is dependent on the ability of Nef to induce
the activation of latently infected cells (Fujinaga et al., 1995;
Alexander et al., 1997). Indeed, it has been shown that Nef
perturbs cell activation pathways, thereby influencing viral
replication in host (Skowronski et al., 1993; Quaranta et al.,
1999). HIV-1 Nef was also shown to interfere with numerous
kinase phosphorylation pathways inducing cell activation and
extracellular signaling (Blagoveshchenskaya et al., 2002; He et
al., 2004; Suzu et al., 2005; Lee et al., 2005; Fenard et al., 2005;
Mann et al., 2005; Wei et al., 2005).
SIVsmm PBj14 is a unique strain of SIV which was isolated
from a pig-tailed macaque (Macaca nemestrina) PBj at the time
of its death, 14 months after inoculation with SIVsmm9 (Fultz,
1989). SIVsmm PBj14 differs from other primate lentiviruses in
that, it induces a hyperacute disease syndrome which is marked
by a rapid induction of T cell activation and proliferation,
particularly in gut-associated lymphoid tissues ending with
death of pig-tailed and cynomologus macaques and sooty
mongabeys (Fultz, 1989) within 6–10 days following virus
inoculation. The acute pathogenic effects of this virus appeared
to be associated with at least two in vitro characteristics: the
ability of the virus to induce lymphocyte activation and
proliferation and also to replicate in resting mononuclear cells
in which the CD4+ Tcells become activated following infection
with the virus (Fultz and Zack, 1994; Thai and Fultz, 1998;
Rosenberg et al., 1991). Earlier data established that the protein
encoded by the nef gene of SIVsmm PBj14 were directly
responsible for the activation of resting PBMC. However, the
mechanism of this Nef-dependent process still remains poorly
characterized because subsequent replication of the virus in the
cells caused their death. Two amino acids in Nef PBj14 (aa 17
tyrosine and aa 18 glutamic acid) were shown to be strongly
linked to this process of lymphocyte activation (Saucier et al.,
1998; Dehghani et al., 2002b). Whether these activated
lymphocytes are massively killed by the virus infection or by
apoptotic death that results from the activation cascade process
is not well established.
The implication of SIV and HIV Nef in apoptosis regulation
has already been suggested. Recent studies have shown thatHIV-1 Nef protects infected cells from apoptosis (Yoon et al.,
2001; Geleziunas et al., 2001). A functional interaction between
Nef and the cellular protein ASK1, known as an inhibitor of
anti-apoptotic factors, induces the anti-apoptotic activity via
Bcl2 and Bcl-XL. Such interaction demonstrated that Nef was
implicated in the regulation of the apoptosis process. In contrast,
Nef has been described as a strong apoptosis inducer both in
vitro and in vivo (Johnson, 1997; Rasola et al., 2001; Zauli et
al., 1999) via the activation of Fas/Fas-ligand pathway. Indeed,
in HIV-1 and SIV infections, Fas and FasL have been shown to
be upregulated in CD4+ and CD8+ T cells of HIV-1-infected
patients or SIV-infected macaques and in cultured human Tcells
following their infection with HIV-1. Further, these lympho-
cytes were shown to have increased susceptibility to Fas-
mediated killing (Blagoveshchenskaya et al., 2002). This
mechanism of induction of apoptotic cell death of CD4+ and
CD8+ T cells by HIV-1 or SIV via activation of FasL or Fas
expression was found to be dependent on a functional Nef
protein (Yoon et al., 2001; Johnson, 1997) and involves p38
mitogen-activated protein kinase (Muthumani et al., 2005). In
addition, the upregulation of FasL on HIV-1-infected macro-
phages has been reported to mediate the apoptosis of uninfected
T cells (Okada et al., 1997a, 1997b, 1998). HIV-1 Nef was
shown to promote phenotypic and functional differentiation of
dendritic cells that induce activation of T lymphocytes
(Quaranta et al., 2002). Recently it was reported that HIV Nef
induces suppression of CD40-dependent immunoglobulin class
switching in bystander B cells (Qiao et al., 2006). However,
despite these observations, a clear demonstration of the action
of Nef in bystander non-infected T cells has never been
unequivocally proven because death of cells from infection
could not be disproved.
In the experiments reported here, we examined whether
SIVsmm PBj14 Nef could induce biological modifications on
bystander lymphocytes when cocultivated with monocyte
derived macrophages (MDMs) expressing the Nef. We
developed a lentiviral model, based on the genome of the
caprine arthritis encephalitis virus (CAEV). CAEV is a proto-
typic lentivirus closely related to the primate lentiviruses HIV
and SIV, but in contrast to these viruses CAEV lacks nef, vpu,
vpr and vpx accessory genes (Narayan et al., 1982, 1983). The
virus replicated productively in macropahges but does not
infect CD4+ T cells nor does it induce AIDS in infected goats.
We generated a chimeric virus called CAEV-nef that carries
the coding sequences of SIVsmm pBJ14 nef in addition of all
coding sequences of CAEV. This virus was shown to be
infectious, replication competent in goat MDMs, and in goat
synovial membrane cells (GSMs) and to constitutively express
SIV Nef in infected cells. Coculture of goat MDMs infected
with CAEV-nef with goat PBMCs showed overexpression of
IL-2R at the surface of goat lymphocytes, a marker of activation
that was correlated with increased proliferation of the cells.
Kinetic studies on the cocultivated PBMCs showed that the
cells exposed to goat MDMs expressing Nef were first protected
from apoptotic cell death in the early stage of exposure and then
succumbed to apoptosis later. PCR examination of cocultured
PBMCs revealed lack of infection in these cells.
Fig. 1. Structural organization of parental CAEV, SIV and CAEV-nef chimeric
genomes. SIV PBj14 nef coding sequences were amplified by PCR using
specific primers as shown in panel a. The PCR product containing the end of
CAEV tat, the 60 nucleotide spacer and the complete coding sequences of
SIV PBj14 nef was sub-cloned into pGEMt plasmid then re-isolated following
double digestion with Sma-1 and Spe-1 enzymes. This fragment was inserted
into the unique Sma-1 site of CAEV (b) genome to generate CAEV-nef
chimeric genome (c). The locations of primers used for PCR and expected
PCR products are represented by arrows and solid bars, respectively, under
each genome.
Fig. 2. Detection of SIV Nef expression by immunocytochemistry and radioimmunop
(c) GSM cells were incubated successively with a primary anti-Nef mouse polyclonal
staining was obtained following incubation in a solution containing streptavidine–bi
were incubated with 35S-methionine and cysteine and radiolabelled protein were imm
normal non-infected goat (1) with serum from a hyperimmune goat infected with CA
and a rabbit polyclonal anti-Nef serum (3) that immunoprecipitates the SIV Nef p34
methods and commercial high molecular weight protein marker for protein size dete
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CAEV-nef chimeric virus is infectious and replication
competent
The genomic organization of the CAEV-nef recombinant
virus and the parental CAEV is shown in Fig. 1. The full-length
infectious molecularly cloned genome derived from the CO
strain of CAEV, named CAEV (Fig. 1b) (Mselli-Lakhal et al.,
2000), was used as a vector to insert the coding sequences for
Nef isolated from the genome of SIV-PBj14 (Fig. 1a) as des-
cribed in Materials and methods (Fig. 1c). To produce virus
stocks from both genomes, plasmid DNAs were transfected into
semi confluent monolayers of GSM cells and supernatant fluids
collected 5 days later were titrated in GSM cells and used to
inoculate fresh GSM cells at MOI=0.1 for virus stock
production. Titers of virus stocks were harvested on days 3, 5
and 7 post-inoculation in GSM cells that measured 104, 105.5
and 106 TCID50/ml for CAEVand 10
4.5, 106 and 107 TCID50/ml
for CAEV-nef, respectively. These data showed that CAEV-nef
replicated with a slightly higher efficiency than parental CAEV
despite having a 10% increase of the size of its genome by the
insertion of nef. Immunocytochemical analysis using a mouse
polyclonal antibody specific to SIV Nef showed efficientrecipitation, RIPA. Non-infected (a), CAEV-infected (b) and CAEV-nef-infected
antibody and a secondary biotinylated polyclonal rabbit anti-mouse Ig. Specific
otin–peroxidase complex. For RIPA analysis (d) CAEV-nef-infected GSM cells
unoprecipitated from the supernatant (S) and cell lysate (C) with serum from a
EV (2) that immunoprecipitated the major Gag p25 and Env gp170 and gp 135,
. Proteins were separated in SDS–PAGE and autoradiographied using standard
rmination.
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GSM cells (Fig. 2c). In addition, the 34-kDa Nef protein was
specifically immunoprecipitated from the cell lysate of infected
GSM cells (Fig. 2d).
Monolayers of GSM cells inoculated with CAEV and
CAEV-nef at MOI=0.1 were examined at day 7 post-infection
(Fig. 3). The evaluation of induced CPE was performed by
scoring the number of nuclei per syncitium in 20 randomly
selected syncitium and the number of syncitium per field in 20
randomly selected microscopic fields in infected GSM cells
stained by May–Grünwald–Giemsa. The data were used to
determine the average values and to plot the histograms reported
in Figs. 3d–e. The results showed clearly that infection with the
chimeric CAEV-nef caused increased CPE characterized by
higher numbers of syncitium and higher numbers of nuclei per
syncitium as well.
SIV Nef induces activation of goat lymphocytes
Because IL-2 receptor expression at the surface of lympho-
cytes is closely related to the activated state of the cells, we
kinetically measured the IL-2 R expression on goat PBMCs
following their contact with non-infected, CAEV and CAEV-
nef-infected goat MDMs. Monolayers of goat MDMs in 6-well
plates (105 cells/well) were inoculated with 104 TCID50 of
CAEV and CAEV-nef. At day 3 post-inoculation, 5×106
PBMCs freshly prepared from the same goat were cocultured in
suspension with MDM monolayers. Samples of 0.5×106 cells
in suspension harvested at days 2, 5, 7, 12 and 15 were stainedFig. 3. Evaluation of induced CPE in infected GSM cells Non-infected (a), CAEV
Grünwald–Giemsa at 1 week post-inoculation. The numbers of nuclei per syncitiu
determined and used to plot the graph (d) with the mean of nuclei per syncitium. The
and the average values were used to plot the graph (e) with the mean of syncitia pewith an antibody specific to goat IL-2 receptor and analyzed by
flow cytometry. Except for the day two samples, the proportion
of cells expressing IL-2R was continuously higher from day 5 to
day 15 among lymphocytes cocultured with macrophages in-
fected with CAEV-nef compared to non-infected or CAEV-
infected macrophages (Fig. 4). To ensure that goat lymphocytes
were not infected with the chimeric virus when cocultured with
infected MDMs, DNA was isolated from samples of cells in
suspension and used for PCR analysis. DNAwas isolated from
infected macrophages were used as positive control. The data in
Fig. 5 show clearly the successful amplification of PCR pro-
ducts with the expected sizes with macrophage DNA samples
but not with lymphocyte DNAs in which only the 393-bp
corresponding to actin product was amplified. The negative
result of PCR analysis ruled out the possibility that the increased
activation of PBMC seen in coculture with CAEV-nef infected
MDMs was the result of direct infection of more than few of
these cells.
Altogether, these data demonstrated that exposure of goat
PBMCs to CAEV-nef-infected macrophages induced an
increased proportion of IL-2R expressing goat lymphocytes in
absence of their infection. We therefore concluded that SIV Nef
induced a bystander activation of goat lymphocytes.
The activation of goat lymphocytes by SIVsmm PBj14 Nef is
associated with an increased proliferation activity
Since the Nef protein of SIV PBj14 is well known for its
mitogenic effects on macaque lymphocytes both in vitro and in-infected (b) and CAEV-nef (c) -infected GSM cells were stained with May–
m in 20 randomly chosen syncitia were scored and the average values were
numbers of syncitia per field of vision in 10 randomly chosen fields were scored
r field of vision.
Fig. 5. PCR analysis of DNA isolated from macrophage and lymphocyte cultures Goat MDMs infected with CAEVand CAEV-nef were cocultured with fresh PBMCs
and 7 days later DNAs were isolated from cells in suspension and from MDM monolayers. DNA samples were examined by PCR using CAEV tat/env and SIV nef
primers. Actin primers were used as internal controls to ensure the quality and quantity of DNA. The primers specific to tat and env sequences should generate an
amplified fragment DNA containing 142 bp and 1226 bp from CAEVand CAEVpBSCAnef genomes respectively. The primers specific to SIV nef coding sequences
amplify a PCR product of 1084 bp from CAEVpBSCAnef genome only. Actin primers generate a PCR product of 393 bp specific. Samples 1, 4, 7 and 10 are DNAs
from non-infected cells, 2, 5, 8 and 11 from CAEV-infected and 3, 6, 9 and 12 from CAEV-nef-infected cells. PCR amplification was performed as described in
Materials and methods, and 10 μl of aliquots from each sample was separated by electrophoresis on 1.5% agarose gel, and then DNA product was visualized by
staining with ethidium bromide.
Fig. 4. Analysis of kinetics of IL-2R expression on the surface of goat lymphocytes: The kinetic expression of the IL-2R was performed on goat PBMCs following
coculture with MDMs infected with CAEVand CAEV-nef viruses. PBMCs cocultured with non-infected MDMs were used as negative control (NC). At different days
post-coculture, PBMCs were stained with monoclonal antibody specific to goat IL-2R. Evaluation of expression of this receptor at the surface of lymphocytes was
performed by the selective flow cytometry analysis of this cell population according to their forward-scatter versus side-scatter characteristics as shown in the R1 gate
of viability dot plot of lymphocytes in goat PBMCs. The specificity of this antibody was examined in normal and PHA-stimulated PBMCs as shown in the histograms
in the top of the figure. Activated lymphocytes are presented in graphic as the percentage of IL-2R expressing cells.
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tion of lymphocytes cocultured with MDMs infected with the
virus. Using the incorporation of BrdU method, we examined in
parallel the proliferative activity of goat PBMCs cocultured
with non-infected macrophages and CAEV-nef and CAEV-
infected MDMs. In one coculture of PBMCs with non-infected
macrophages, PHA and IL-2 were added to stimulate lympho-
cyte proliferation as positive control. Samples of 0.5×106 cellsFig. 6. Proliferation of goat lymphocytes induced by SIV Nef. The kinetics of prolifer
cells with MDMs infected with CAEV and CAEV-nef, respectively. PBMCs cocul
cocultured with non-infectedMDMs and treated with PHA/IL-2 were used as a positiv
were incubated with BrdU and stained for its incorporation into newly synthesized DN
flow cytometry analysis of lymphocytes according to the forward-scatter versus sid
scatter characteristics are shown on top of the figure, the specificity of the antibody w
the presence of both. Examples of obtained histograms with normal and PHA/stimula
the graphic as the percentage of BrdU incorporating cells.in suspension harvested at days 2, 5, 7, 10, 12 and 15 were
incubated with BrdU and then stained with a specific mAb anti-
BrdU prior to analysis by flow cytometry. The results reported
in Fig. 6 showed 5- to 6-fold higher incorporation rate of BrdU
in all examined samples of lymphocytes from PBMCs that were
in contact with macrophages infected with CAEV-nef. This
higher rate of lymphocyte proliferation was maintained
throughout the 15-day study period. These results showed thatation of goat lymphocyes in PBMCs was examined following cocultures of these
tured with non-infected MDMs were used as negative control (NC) and those
e control (PC). At different days post-coculture, days 2 to 15, samples of PBMCs
A cells. The proportion of proliferating lymphocytes was performed by selective
e-scatter characteristics. Examples of dot plots representing FITC- versus side-
as examined on normal PBMCs in absence of the primary or the secondary and
ted PBMCs are shown in the top of the figure. Obtained values were used to plot
275B.A. Bouzar et al. / Virology 364 (2007) 269–280expression of Nef by CAEV genome in infected MDMs
induced a mitogenic activity in neighboring goat lymphocytes
in absence of their infection with CAEV-nef.
SIVsmm PBj14 Nef protein has a dual role on the modulation
of apoptosis in goat lymphocytes
It is well known that activation of lymphocytes is followed
by apoptosis of the cells reviewed in Thome and Tschopp
(2001) and Tripathi and Hildeman (2004). Since we found that
the exposure of goat lymphocytes to CAEV-infected macro-
phages expressing of SIV Nef resulted in activation and
proliferation in absence of their infection, we wanted to
determine whether these activated proliferating lymphocytes
developed accelerated onset of apoptosis using the coculture
model described above. As positive control, a coculture of
PBMCs with non-infected macrophages was treated with
staurosporine. During the first 7 days of coculture, the pro-
portion of apoptotic lymphocytes following exposure to CAEV-
nef-infected macophages was found to be 2-fold (15%) less than
that observed with lymphocytes exposed to non-infected (29%)
or CAEV-infected (34%) macrophages, while the staurospaur-
ine treated cells showed 50% of apoptotic cells (Fig. 7). In
contrast, at day 12 of coculture, increased apoptosis of lympho-
cytes (63%) was observed with those exposed to CAEV-nef-Fig. 7. Analysis of induced apoptosis in bystander goat lymphocytes. Analysis of ap
infected with CAEVand CAEV-nef. Non-treated PBMCs cocultured with non-infecte
controls, respectively. Samples were examined at days 7 and 12 and the proportion o
the rate of DNA breaks with apostain and examination by flow cytometry. The percen
forward-scatter versus side-scatter characteristics and then measuring the percentage o
was examined normal (nor) PBMCs and PBMCs treated with staurosporin (ST) andinfected MDMs, which was close to the proportion obtained
with the staurosporine-treated cells (75%), while lymphocytes
exposed to CAEV-infected and to non-infected macrophages
showed lower percentages of apoptotic cells (46% and 37%
respectively). Interestingly, the low apoptosis associated with
SIV Nef in goat lymphocytes coincided with the lack of
activation of the cells (before day 9 post-coculture) whereas
increased SIV Nef-induced apoptosis in lymphocytes coincided
with the period when they were activated and in a proliferative
state (day 12 post-coculture).
Discussion
Recently we described a new lentiviral model to study the
function of primate lentivirus accessory genes in the context of
virus infection/replication in MDMs, but in absence of infection
of CD4+ T cells (Bouzar et al., 2003, 2004). Using this model,
we report here the development of a new chimeric virus
expressing the nef gene of the SIVsmm PBj14 by the infectious
genome of CAEV. SIV PBj nef was chosen to illustrate the
proof of the concept because of its well-known abilities to
induce a high level of activation and proliferation of T cells both
in cultures and in animals. Since our aim was to examine
whether there is an effect in a non-natural host of SIV, we
hypothesized that the SIV PBj nef was the best choice to induceoptosis was performed on goat lymphocytes in PBMCs cocultured with MDMs
d MDMs and those treated with staurosporin were used as negative and positive
f lymphocytes that underwent apoptosis was determined following evaluation of
tage of apoptotic lymphocytes was determined by gating cells according to their
f those cells that were FITC positive (Apostain). The specificity of this antibody
examples of histograms are shown in the top of the figure.
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nef virus is still strictly macrophage tropic and could not infect
T cells. These cells nevertheless became activated and under-
went proliferation and apoptosis when exposed to infected
macrophages expressing Nef.
The chimeric genome CAEV-nef was generated by the
insertion of 1 kb sequences of SIV Nef in the 9-kb genome of
CAEV. Despite 10% increase of genome, the resulting chimeric
virus was fully replication competent with titer at least as high
as that of the parental virus and efficiently expressed the
transgene. Interestingly, following 10 serial passages of CAEV-
nef in GSM cells the expression of the transgene was still
detected in infected cells (data not shown). Immunoprecipita-
tion and PCR analysis confirmed that the SIV nef gene was
correctly inserted and the Nef protein consistently expressed in
the infected cells.
Several studies had shown that the ability of SIVsmm PBj14
to cause hyperacute lethal disease was strongly associated with
the ability of the virus to cause activation of resting PBMCs
leading to the enhancement of virus replication. Since studies of
mechanisms of PBMC activation with the SIVsmm PBj14
showed that the nef gene was directly implicated in this process
(Stephens et al., 1998; Dehghani et al., 2002a; Du et al., 1995),
we were interested to determine whether this is a cis-acting
mechanism affecting infected cells only or a trans-acting
mechanism that affects non-infected cells as well. Data here
presented are the first demonstration of cross species interaction
of SIV Nef that induced mitogenic and apoptotic activities in
caprine PBMCs. The activation process as observed with the
increased expression of IL-2R at the surface of goat
lymphocytes correlated with an increased proliferative activity
following exposure to macrophages expressing SIVsmm PBj
Nef. Since lymphocytes were not infected with the virus, the
activation/proliferation processes could have been induced by
soluble factors released by the infected macrophages or by cell
associated factors expressed at the surface of infected macro-
phages, following contact. Since the incubation of goat
lymphocytes with infectious cell-free supernatant fluid of
CAEV-nef-infected macrophages did not result in increased
cell activation/proliferation or apoptosis (data not shown), we
concluded that these processes had been induced via cell
associated factors at the surface of infected macrophages.
Therefore, we concluded that the extracellular Nef that could be
released by lysis of infected cells was not responsible for this
process. Thus, the Nef of SIVsmm PBj14 expressed in goat
macrophages had induced all three biological effects: activation,
proliferation and apoptosis in the lymphocytes without causing
infection in the latter. The results of apoptosis induced in
lymphocytes exposed to Nef-expressing infected MDMs
showed different effects at 7 and 12 days post-exposure.
Indeed, at 7 days Nef showed a protective effect of cells from
undergoing apoptosis. This Nef-induced protection from
apoptosis has been reported earlier and involves two mechan-
isms. Nef induces the protection of cells from apoptosis by
interacting with the external death signal pathways mainly by
the inhibition of Ask1 (Geleziunas et al., 2001). Nef also
mediates the activation of PI3K and PAK resulting inphosphorylation of Bad, a Bcl-2 protein family, which results
in increase of the anti-apoptotic Bcl-XL protein that enhances
the survival of cells (Wolf et al., 2001). Recently Nef was shown
to induce protection of human-monocyte-derived macrophages
from apoptosis induced by HIV-1 (Olivetta and Federico, 2006)
and this protection correlated with a hyperphosphorylation of
the pro-apoptotic Bad protein. In contrast, at 12 days Nef
showed an enhancement of apoptotic death of lymphocytes.
Nef-induced apoptotic death of infected as well as bystander
cells has also been documented. Extracellular Nef has been
suggested to induce apoptosis in PBMCs (Okada et al., 1997b;
James et al., 2004). However, in our experiments, the failure of
the supernatant of Nef-expressing infected MDMs to induce
apoptosis of PBMCs suggested either the rarity of extracellular
Nef in our experimental conditions or this protein is inactive
when not associated with the plasma membrane. Nef has been
also shown to induce apoptosis of microvascular endothelial
cells (Acheampong et al., 2005).
The main pathway used by Nef to induce apoptosis is via
increased expression of FasL in Nef-expressing cells that
allows the killing of bystander T cells via Fas-FasL pathway
(Xu and Screaton, 2001; Fackler and Baur, 2002; Fackler et
al., 1999; Krautkramer et al., 2004). However, the primate
models in which bystanders could be infected by Nef expres-
sing virus could not absolutely exclude the possibility that at
least a proportion of bystander cells in the studies were
infected. This is the first lentivirus model in which the delete-
rious function of the Nef accessory proteins could be demon-
strated in lymphocytes without the complication of infection in
the cells.
Materials and methods
Generation of CAEV/SIVsmm PBj 14 nef chimeric genome
The CAEV-nef genome was derived from the previously
reported CAEV plasmid (Mselli-Lakhal et al., 2000) using a
similar strategy that we recently reported (Villet et al., 2003b;
Bouzar et al., 2003). Briefly, the nef gene was amplified by PCR
from the SIV PBj-14 proviral genome, using the following
primers: 5′-TAA ACC CGG GGT GGG GAA CATAAG GAC
GCT GCA GAG AGC CCG TGA AGT C-3′ (NefPBj5′) and
5′-GCC AGC CTC TCC GCA GAG CGA CTG AAT-3′
(NefPBj3′), that are complementary to the beginning and end of
nef gene, respectively. The Nef PBj5′ primer contains sequences
that restore the end of the coding sequences of CAEV tat gene.
The resulting 1084 bp PCR fragment was subcloned into the
pGEM-t plasmid DNA (Promega, Charbonnieres, France) and
then re-isolated from the pGEM-nef plasmid following double
digestion with Sma1 and Spe1 endonucleases. The Spe1
extremity was transformed in blunt end following Klenow
polymerase treatment, and the resulting product was inserted
into the unique Sma-1 site located at the end of tat and upstream
of env coding sequences of the genome of the infectious
molecular clone CAEV. The resulting recombinant plasmid
DNA that contained the nef gene in the orientation of CAEV
transcription was named CAEV-nef.
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GSM cells were used to produce virus stock and as indicator
cells to quantify the infectivity and cytopathic effects (CPE) of
viruses used in this study. CPE is characterized by development
of foci of multinucleated giant cells. GSM cells were originally
obtained from explanted carpal synovial membranes isolated
from a colostrum-deprived newborn goat as previously
described (Silva Teixeira et al., 1997). These cells were
shown to be highly susceptible to CAEV infection and
development of CPE. The cell line was expanded by cultivation
in minimum essential medium (MEM) supplemented with 10%
fetal bovine serum (FBS, Invitrogen, Montpelier, France) and
propagated by incubation at 37 °C and 5% CO2 with high
humidity. To produce CAEV and CAEV-nef as virus stocks,
5 μg of each corresponding plasmid DNAwas used to transfect
GSM cells (5×105 cells/25 cm2 flask) using the lipofectamine
method (Silva Teixeira et al., 1997). At 18 h post-transfection,
the medium was removed and cell monolayers were washed
three times with phosphate buffered saline (PBS) and then
incubated in fresh medium. Culture medium of cells was
collected on day 5 post-transfection, clarified by filtration
through 0.45-μm membrane filters and used to inoculate fresh
GSM cells in which virus stocks were prepared. Serial 10-fold
dilutions of virus stocks were used to inoculate monolayers of
the indicator GSM cells, and 6 days later cells were stained with
May–Grünwald–Giemsa, and examined for the presence of
CPE. Syncitia were scored and the titers were calculated using
the Reed-Muench method and were expressed as tissue culture
infectious dose (TCID50) per milliliter of virus stock. Virus
stocks had approximately 1×107 TCID50/ml.
To compare the CPE induced by CAEVand CAEV-nef, semi
confluent GSM cell cultures were inoculated at a multiplicity of
infection (MOI) of 0.1 with each virus. Seven days later, cells
were stained with May–Grünwald–Giemsa and observed for
CPE. First we scored the number of nuclei per syncitium in 20
randomly selected syncitia to determine the mean number per
cell. Second we scored the number of syncitia in 10 randomly
selected fields to determine the mean number per field.
The expression of SIV Nef protein was detected by
immunostaining in CAEV-nef-infected GSM cells cultured in
eight chamber slides (Lab Tek). GSM cell monolayers were
inoculated with CAEV and CAEV-nef at MOI of 0.1 and
incubated at 37 °C in 5% CO2. At 5 days post-infection cells
were rinsed with PBS and fixed with acetone. SIV Nef protein
expression was detected using a mouse-specific polyclonal
antibody directed against SIVsmm PBj14 Nef. This serum was
produced following DNA immunization of mice (3 injections of
50 μg each at 1-week intervals) with a plasmid DNA construct
expressing the SIVsmm PBj14 nef gene under the transcrip-
tional control of CMV promoter (data not shown). Cells were
incubated 30 min at 37 °C with the primary anti-Nef polyclonal
antibody diluted (1/200) in PBS containing 1% BSA, PBS/
BSA, washed with PBS and then incubated for 30 min with a
secondary rabbit anti-mouse biotinylated antibody (DAKO Kit,
France) diluted (1/1000) in PBS/BSA. Cells were washed with
PBS, incubated 30 min in PBS solution containing streptavi-dine–biotin–peroxidase complex and then incubated for 10 min
in PBS solution supplemented with 1 mg/ml diaminobenzidine.
The staining was stopped by washing with water and then
darkened following short incubation in osmic acid. Cells were
then counterstained with hematoxylin and mounted in aqueous
mounting medium. Appropriate negative controls were in-
cluded for the specificity of anti-Nef antibody.
For radioimmunoprecipitation (RIPA) analysis, cells were
labeled with 35S-methionine and cysteine and viral proteins
were specifically immunoprecipaitated using a polyclonal
serum anti-CAEV or anti-SIV Nef as previously described
(Chebloune et al., 1996; Hegde et al., 2005). Proteins were
separated on SDS–PAGE and bands revealed by autoradio-
graphy using the standard methods.
Isolation of goat PBMCs and derivation of macrophages
Goat peripheral blood mononuclear cells, PBMCs, were
isolated by density-gradient centrifugation of blood using the
Ficoll method, as previously described (Guiguen et al., 2000).
Briefly, 50 ml of blood collected by venipuncture in 2 mM
EDTAwas centrifuged at 400×g for 5 min at 20 °C to separate
the red blood cells from the plasma. Buffy coats were harvested
and diluted three times in Hanks solution containing 2 mM
EDTA. PBMCs were purified following centrifugation at 400 g
for 45 min at 20 °C through Ficoll-Hypaque gradients
(Histopaque 1.077, Sigma, France). Two types of cells were
derived from the PBMCs. First, to push monocytes to
differentiate into macrophages, PBMCs were resuspended into
15 ml of medium consisting of RPMI 1640 (Invitrogen,
Montpelier, France) supplemented with 10 mM HEPES buffer,
0.05 mM 2-β-mercapthoethanol, 2 mM glutamine, 0.05 mg/ml
gentamicin and 20% heat inactivated lamb serum (Invitrogen,
Montpelier, France) and were maintained in sterile polypropy-
lene tubes at 37 °C for 5–7 days where the monocytes
differentiated into MDMs. Cells were then transferred to 6-well
plates where the MDMs immediately established monolayers.
One day later, the non-adherent cells were removed and the
adherent MDMs rinsed twice with medium. MDM cultures
were then incubated in 2 ml of fresh medium or inoculated with
2 ml of infectious medium containing 104 TCID50 of CAEV-nef
and CAEV at MOI=0.1. Three days later, freshly isolated
PBMCs from the same goat were resuspended in R10 consisting
of RPMI 1640 (Invitrogen, Montpelier, France) supplemented
with 10 mM HEPES buffer, 0.05 mM 2-β-mercapthoethanol,
2 mM glutamine, 0.05 mg/ml gentamicin and 10% of heat
inactivated fetal bovine serum (FBS, Invitrogen, Montpelier,
France) and human recombinant (Hr) IL-2 (0.25 IU/mL;
Interchim). Two milliliters of medium containing 5×106
PBMCs was added to monolayers of MDM cultures, uninfected
as well as MDMs infected with each of the two viruses.
Analysis of IL-2R expression as indicator of lymphocyte
activation
To assess kinetics of expression of the interleukin 2 receptor
(IL2-R) on the surfaces of activated lymphocytes, goat PBMCs
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goat MDMs were harvested on different days following
coculture and stained with anti-goat IL2-R monoclonal anti-
body (VMRD, La Jolla). The cells were transferred into 96-
well round bottom tissue culture plates at a density of 0.5×106
per well. Cells were washed with PBS (centrifugation at
800×g, 2 min, 4 °C) and then incubated, 30 min at 4 °C, with
the primary mouse monoclonal antibody directed against goat
IL2-R (dilution: 1.5% in PBS/BSA, VMRD). After two rinses
with PBS, cells were incubated 30 min at 4 °C with a
secondary FITC-conjugated anti-mouse antibody (SIGMA-
Aldrich, la Verpillere, France) diluted in PBS/BSA. Cells were
then rinsed and fixed in 1% paraformaldehyde. The samples
were analyzed using LYSYS II software and a minimum of
105 cells in a Becton Dickinson Facscan instrument.
Lymphocytes were gated according to forward-scatter versus
side-scatter characteristics.
Proliferation assay of goat lymphocytes
PBMC proliferation was evaluated by incorporation of BrdU
into goat PBMCs from the cocultures with goat macrophages.
As a positive control, a coculture of goat PBMCs with non-
infected goat macrophages was treated with phytohemagluti-
nine (PHA, 2 μg/ml, SIGMA-Aldrich, la Verpillere France) for
3 days and human recombinant (Hr) IL-2 (0.25 IU/mL;
Interchim). At different days post-coculture, samples of
0.5×106 cells were incubated for 1 h with 10 μM of 5-
bromo-2′-deoxyuridine (BrdU) that allows the incorporation of
BrdU into DNA in cells engaged in DNA synthesis. Cells were
then rinsed twice with PBS and fixed for 1 h at +4 °C by
addition of 50% ethanol (prechilled to −20 °C). Cells were then
centrifuged for 10 min at 800×g. To depurinate chromosomal
DNA, samples were treated with 2 N HCl for 30 min at room
temperature. After several washing steps with PBS 0.5% Tween
20, the pH of the cell suspension was adjusted to 7.2 to 7.5. To
detect cells that had entered the S phase, cells were incubated
for 30 min at room temperature with FITC-conjugated mouse
anti-BrdU monoclonal antibody (DAKO, Trappes, France).
Cells were then rinsed twice with PBS 0.5% Tween 20,
resuspended in PBS and then analyzed on a Becton Dickinson
Facscan instrument equipped with LYSYS II software for a
minimum of 105 cells by gating lymphocytes according to
forward-scatter versus side-scatter characteristics.
Evaluation of apoptosis in goat lymphocytes
Samples of goat PBMCs were harvested and analyzed for
DNA breaks using the Apostain mAb to ssDNA (F7-26)
commercial kit (Alexis Biochemicals, France) according to the
manufacturer's instructions. The Apostain test quantitates
apoptosis at the single-cell level after DNA denaturation by
heating at a low temperature in the presence of formamide and
staining with a monoclonal antibody (Mab) F7-26 specific to
single-stranded DNA (ssDNA). As positive controls, goat
PBMCs were stimulated to undergo apoptosis by treatment with
20 μM of staurosporine (SIGMA-Aldrich, La Verpillere,France). PBMCs cocultured with non-infected MDMs were
used for each experiment as negative controls. The percentages
of apoptotic cells reported in the figure were defined as the
proportion of cells containing fluorescein label in their DNA.
Stained cells were acquired by flow cytometry and lymphocytes
gated according to forward-scatter versus side-scatter character-
istics were analyzed by the Lysis II analysis Software at a 488-
nm argon ion laser.
PCR analysis
Goat MDMs inoculated with CAEV and CAEV-nef at MOI
of 0.1 in 25 cm2 tissue culture flasks (5×105 cells/flask), and
3 days later they were cocultured with fresh PBMCs (107 cells/
flask). At day 7 post-coculture DNA was isolated from cells in
suspension and from macrophage monolayers (Quiagen,
DNeasy Tissue Kit, France) and samples of these DNAs were
used as templates for PCR analysis using two sets of
oligonucleotide primers: 5′-GAT TAG GGC CTG TGG ATG
CAG-3′ (tat) and 5′-CAG TTA AGC GCATGTATC TGG-3′)
(env) specific to CAEV tat and env genes and 5′-CAT AAG
GAC GCT GCA GAG AGC CCG TGA AGT C-3′ (NefPBj5′)
and 5′-GCC AGC CTC TCC GCA GAG CGA CTG AAT-3′
(NefPBj3′) complementary to SIVsmm PBj14 nef coding se-
quences. The primers specific to tat and env sequences should
generate an amplified fragment DNA containing 142 bp and
1226 bp from CAEV and CAEVpBSCAnef genomes, respec-
tively. The primers specific to SIV nef coding sequences
amplify a PCR product of 1084 bp from CAEVpBSCAnef
genome only. Oligonucleotides primers ES30: 5′-TCA TGT
TTG AGA CCT TCA ACA CCC CAG-3′ and ES32: 5′-CCA
GGGGAAGGC TGGAAGAGTGCC-3′, that generate a PCR
product of 393 bp specific to the fourth exon of β-actin gene
were used as an internal control for cellular DNA detection.
PCR amplification was performed using the following
parameters: initial DNA denaturation at 94 °C for 5 min,
followed by 35 cycles of denaturation at 92° for 1 min,
annealing at 56 °C for 1.5 min and primer extension at 70 °C for
2.5 min; a final incubation for 15 min at 70 °C was performed to
terminate initiated DNA synthesis. After PCR amplification,
10 μl of aliquots from each sample was separated by
electrophoresis on 1.5% agarose gel, and then DNA product
was visualized by staining with ethidium bromide.
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